Zimbabwe: Zimbabwe Is The First County In Africa To Announce Regulatory Approval For Long-Acting Injectable Cabotegravir For HIV Prevention

[WHO] Today, the Medicines Control Authority of Zimbabwe announced that it has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news